P1.08D.01 The Efficacy of Durvalumab after Concurrent Chemoradiotherapy for EGFR-Mutated Stage III Non-Small Cell Lung Cancer (NEJ063)

• Published in: Journal of thoracic oncology Vol. 19; no. 10; pp. S182 - S183
• Main Authors: Kida, G., Fujisaki, T., Miyauchi, E., Kikuchi, H., Hommura, F., Yokoo, K., Tanaka, H., Kikuchi, T., Jingu, D., Sugisaka, J., Watanabe, K., Yoshimura, N., Nakagawa, T., Nogawa, H., Sato, M., Nakazawa, K., Soda, S., Takigami, A., Arai, D., Masubuchi, K., Miura, Y., Nagai, Y., Matsumoto, N., Oba, T., Namba, Y., Ashinuma, H., Saito, G., Kamimura, M., Takahashi, S., Isobe, K., Miyawaki, T., Nishiyama, K., Sakashita, H., Nozaki, K., Inomata, M., Umeda, Y., Tateishi, K., Tetsumoto, S., Tamiya, M., Tsubata, Y., Masuda, K., Obata, H., Yamaji, Y., Harada, M., Ohnishi, H., Nakao, A., Morita, S., Maemondo, M.
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.10.2024